Claudia S. Castro, PharmD, MS, BCOP, BCGP

Articles by Claudia S. Castro, PharmD, MS, BCOP, BCGP

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

ByClaudia S. Castro, PharmD, MS, BCOP, BCGP,Amanda Manoogian, PharmD, BCOP

August 26th 2020

The increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.

Latest Updated Articles

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective
Published: August 26th 2020 | Updated:

Claudia S. Castro, PharmD, MS, BCOP, BCGP

Articles by Claudia S. Castro, PharmD, MS, BCOP, BCGP

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

Latest Updated Articles

Trending on Pharmacy Times

Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate

Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A